Abstract
Outbreaks of Clostridium difficile-associated disease (CDAD), especially the hypervirulent North American pulsed field gel electrophoresis type 1 strain, have presented significant problems for patients, hospitals, long-term care facilities, and clinicians [1-3]. The important study by Dubberke et al. [4] in this issue of Clinical Infectious Diseases calls attention to the financial burden facing hospitals and, indirectly, to payers. As noted by Dubberke et al. [4], their findings are conservative, as we will discuss further.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
